Wogonin suppresses tumor development and the generation of HIF‐1α, glycolytic enzymes, and PI3K/AKT, highlighting its potential as an effective treatment against hypoxia‐induced chemoresistance [256]. The gene discussed is AKT1; the disease is neoplasm.